Skip to main content
. Author manuscript; available in PMC: 2024 May 23.
Published in final edited form as: Eur J Immunol. 2021 Dec 7;51(12):2708–3145. doi: 10.1002/eji.202170126

Figure 139.

Figure 139.

Gating strategy for human bone marrow MSCs. Biocoll gradient-purified and in vitro-expanded cells from human bone marrow are gated to exclude doublets and cells expressing CD45. As a next step, live single MSCs are identified as cells negative for CD34 and CD31 and then analyzed for their positive expression of CD73, CD105 and CD90.